The Department of the Air Force (DAF) is seeking innovative defense-related dual-purpose health and medical technologies through its Direct-to-Phase-II SBIR opportunity, specifically targeting Airmen Health and Medical Technology solutions. Proposals must align with one of four subcategories: Biotechnology, Combat Casualty Care, Military Infectious Diseases, or Medical Force Readiness, and should demonstrate a mature non-defense technical solution ready for adaptation to meet Air Force needs. This initiative aims to explore and prototype validated concepts that can enhance both defense and non-defense markets, with a focus on applied research and development rather than basic research. Interested parties must submit their proposals by June 5, 2025, with further details available at the DOD SBIR/STTR website.